Advertisement

Reactions Weekly

, Volume 1775, Issue 1, pp 153–153 | Cite as

Dabrafenib/trametinib

Myasthenia gravis: case report
Case report
  • 20 Downloads

Reference

  1. Zaloum A, et al. Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma. Canadian Journal of Neurological Sciences 46 (Suppl. 1): S19 abstr. P.022, Jun 2019. Available from: URL: http://doi.org/10.1017/cjn.2019.122 [abstract] - Canada

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations